COMMUNIQUÉS West-GlobeNewswire

European regulatory authority adopts a positive opinion for an update of the Wegovy® label to reflect risk reduction of major adverse cardiovascular events

25/07/2024 - 17:08

Bagsværd, Denmark, 25 July 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of the Wegovy [...]

Press Release: Online availability of Sanofi’s half-year financial report for 2024

25/07/2024 - 16:57

Online availability of Sanofi’s half-year financial report for 2024 Paris, July 25, 2024 . Sanofi announces that its half-year financial report for the period ending June 30, 2024 is now available and has been filed [...]

Communiqué de presse : Mise en ligne du rapport financier semestriel 2024 de Sanofi

25/07/2024 - 16:57

Mise en ligne du rapport financier semestriel 2024 de Sanofi Paris, le 25 juillet 2024 . Sanofi annonce aujourd’hui avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers (AMF) son [...]

Positron Corporation Introduces New, Advanced Designed, Economically Priced PET-CT

25/07/2024 - 15:28

Niagara Falls, NY, July 25, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET & PET-CT imaging systems, is [...]

60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support

25/07/2024 - 15:02

60 Degrees Pharmaceuticals has been awarded a contract with the United States Army Medical Materiel Development Activity to facilitate commercial validation of new bottle and replacement blister packaging of ARAKODA [...]

Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024

25/07/2024 - 15:00

BEDFORD, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its [...]

Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven

25/07/2024 - 15:00

Company’s continued growth and improved cash position alleviates the need for capital raise in the foreseeable future NEW HAVEN, Conn., July 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, [...]

Intuitive President David J. Rosa Appointed to Intuitive Board of Directors

25/07/2024 - 15:00

SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that Intuitive President [...]

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

25/07/2024 - 14:30

Extends maturity of long-term debt as Fortress‘ late-stage pipeline continues to advance and may generate up to three regulatory approvals on NDAs and BLAs in the next 12 months and potentially a fourth BLA filing as [...]

IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st

25/07/2024 - 14:30

Winter Springs, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 second quarter financial results before the market opens on Thursday, [...]

Inozyme Pharma Publishes Preclinical Data Supporting INZ-701 as a Potential Therapy for a Broad Range of Serious Rare Diseases Impacting Bone Health and Blood Vessel Function

25/07/2024 - 14:30

- Treatment with INZ-701 shown to prevent intimal proliferation in both ENPP1-deficient and wild-type mice, supporting its potential therapeutic application beyond traditional ERT - BOSTON, July 25, 2024 (GLOBE NEWSWIRE [...]

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

25/07/2024 - 14:30

Southlake, TX, July 25, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”) , an artificial intelligence (AI)-powered medical technology [...]

HNL Lab Medicine Opens Gilbertsville Location

24/07/2024 - 22:50

ALLENTOWN, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- HNL Lab Medicine, a leading diagnostics laboratory, announced the opening of a new Patient Service Center. Located at 1107 Grosser Road, Gilbertsville PA, this new [...]

Amedisys Reports Second Quarter 2024 Financial Results

24/07/2024 - 22:30

BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and [...]

Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference

24/07/2024 - 22:05

FRANKLIN, Tenn., July 24, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to [...]

TransCode Therapeutics, Inc. Announces Closing of Public Offering

24/07/2024 - 22:05

BOSTON, July 24, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to more effectively treating cancer using RNA [...]

Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024

24/07/2024 - 22:05

LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated [...]

Psyence Biomed Announces Export of Nature-Derived Psilocybin to Australia and Provides Update on Upcoming Phase IIb Trial

24/07/2024 - 22:05

Trial projected to be initiated shortly following receipt of drug product by trial sites NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today [...]

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

24/07/2024 - 22:01

CAMBRIDGE, Mass., July 24, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today [...]